Advertisement
The new disposable fixed-tip electrode line features hand activation forsurgeons who prefer to energize the electrode via a fingertip switch ratherthan pressing their foot on a foot pedal.
Advertisement
"The introduction of our disposable hand switching, fixed-tip electrodeline is a major step in fulfilling our goal of presenting customers with bothdisposable and reusable options in the laparoscopic instruments they prefer,"said Jack Serino, Encision President & CEO.
"We are pleased to provide the ultimate in patient safety with our AEM(R)technology along with best of class ergonomic instruments. Besides offeringsurgeons AEM at their fingertips, the new disposable fixed-tip electrodesfeature an easy to reach rotation knob with a locking feature and a comfortgrip handle. Hand-activated instruments represent a growing market segmentthat our Company is pleased to participate in with this new product line."
The new product line consists of a disposable handle with integral cordand disposable electrodes available in six popular tip styles. The disposableelectrodes are available in both 35cm lengths for routine procedures and 45cmlengths for bariatric procedures.
Encision Inc. designs, develops, manufactures and markets innovativesurgical devices that allow surgeons to optimize technique and patient safetyduring a broad range of surgical procedures. Based in Boulder, Colorado, theCompany pioneered the development of patented AEM(R) Laparoscopic Instrumentsto improve electrosurgery and reduce the chance for patient injury inminimally invasive surgery. For further information about Encision's line oflaparoscopic instruments, please visit http://www.encision.com
In accordance with the safe harbor provisions of the Private SecuritiesLitigation Reform Act of 1995, the Company notes that statements in this pressrelease and elsewhere that look forward in time, which include everythingother than historical information, involve risks and uncertainties that maycause actual results to differ materially from those indicated by theforward-looking statements. Factors that could cause the Company's actualresults to differ materially include, among others, its ability to increasenet sales through the Company's distribution channels, insufficient quantityof new account conversions, insufficient cash to fund operations, scale upproduction to meet delivery obligations, delay in developing new products andreceiving FDA approval for such new products and other factors discussed inthe Company's filings with the Securities and Exchange Commission.CONTACT: Marcia McHaffie Encision Inc. 303-444-2600 [email protected]
SOURCE Encision Inc.
